Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Kidney360|April 4, 2022
Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020Shruti Gupta, Frank B Cortazar, Leonardo V Riella, et al.
American Journal of Physiology. Renal Physiology|September 8, 2017
Acute blood loss stimulates fibroblast growth factor 23 productionSeham Rabadi, Ikemesit Udo, David E Leaf, et al.
Acta Haematologica|November 3, 2010
A severe case of cefoxitin-induced immune hemolytic anemiaDavid E Leaf, Nathaniel B Langer, Mark Markowski, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 6, 2014
Plasma catalytic iron, AKI, and death among critically ill patientsDavid E Leaf, Mohan Rajapurkar, Suhas S Lele, et al.
Nature Reviews. Nephrology|September 28, 2022
Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injuryBen Sprangers, David E Leaf, Camillo Porta, et al.
The Journal of Applied Laboratory Medicine|December 31, 2020
Stability of Fibroblast Growth Factor 23 in Human PlasmaSalena Cui, Sucheta M Vaingankar, Anneke Stenger, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2014
Randomized controlled trial of calcitriol in severe sepsisDavid E Leaf, Anas Raed, Michael W Donnino, et al.
STAR Protocols|November 17, 2021
Protocol to assess performance of crisis standards of care guidelines for clinical triageLouis T Merriam, Maheetha Bharadwaj, Julia L Jezmir, et al.
Critical Care (London, England)|April 19, 2015
Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patientsDavid E Leaf, Heather E Croy, Sara J Abrahams, et al.
Clinical Endocrinology|February 19, 2013
Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomesDavid E Leaf, Sushrut S Waikar, Myles Wolf, et al.
Pageof 13